Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

25 March 2026 : Laboratory Research  

ODF3B Promotes the Progression of Clear Cell Renal Cell Carcinoma via the JAK/STAT Signaling Pathway

Yongyang Yun ORCID logo ABCDEFG 1,2,3,4*, Xing Ji ORCID logo ABCD 1,2,3,4, Tianyu Wu AE 1,2,3,4, Yixiao Liu ORCID logo AE 1,2,3,4, Zheng Li AE 1,2,3,4, Zhoujie Sun ORCID logo AE 1,2,3,4, Peimin Zhou AE 1,2,3,4, Lei Yang AE 1,2,3,4, Wei Yu ABCDEFG 1,2,3,4

DOI: 10.12659/MSM.951100

Med Sci Monit 2026; 32:e951100

Figure 5 (A, B) Cell proliferation measured after Colivelin TFA treatment in outer dense fiber of sperm tails 3B (ODF3B)-knockdown cells. (C–F) Apoptosis analysis by flow cytometry after Colivelin TFA treatment following ODF3B knockdown. (G–I) Expression of apoptosis-related and Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway proteins after Colivelin TFA treatment in ODF3B-silenced cells.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750